Drug Side Effects

ACQUIRED GENE MUTATION

This adverse event was reported 1291 times

These drugs are most commonly taken by patients reporting ACQUIRED GENE MUTATION:

# Drug Count
0 OSIMERTINIB 473
1 GEFITINIB 258
2 DOXORUBICIN 144
3 LAMIVUDINE 142
4 LAMIVUDINE ORAL 142
5 PREDNISOLONE 127
6 PREDNISOLONE ORAL 127
7 PREDNISOLONE ORAL SOLUTION 127
8 RITUXIMAB 113
9 CYCLOPHOSPHAMIDE 110
See all common drugs associated with ACQUIRED GENE MUTATION

ACQUIRED GENE MUTATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GEFITINIB 258 0.0289
1 OSIMERTINIB 473 0.0162
2 AFATINIB 38 0.0058
3 NEVIRAPINE 50 0.0056
4 ERLOTINIB HYDROCHLORIDE 64 0.0052
5 ERAVACYCLINE 1 0.0049
6 SONIDEGIB 7 0.0048
7 LAMIVUDINE 142 0.0047
8 SELPERCATINIB 5 0.0042
9 TENOFOVIR DISOPROXIL FUMARATE TABLETS 35 0.0041
See all drugs enriched for association with ACQUIRED GENE MUTATION

These drug classes are most commonly taken by patients reporting ACQUIRED GENE MUTATION:

# Drug class Count
0 Kinase Inhibitor [EPC] 673
1 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 164
2 Corticosteroid [EPC] 163
3 Platinum-based Drug [EPC] 158
4 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 149
5 Alkylating Drug [EPC] 139
6 CD20-directed Cytolytic Antibody [EPC] 113
7 Folate Analog Metabolic Inhibitor [EPC] 110
8 Vascular Endothelial Growth Factor Inhibitor [EPC] 67
9 Microtubule Inhibitor [EPC] 61
See all common drug classes associated with ACQUIRED GENE MUTATION

ACQUIRED GENE MUTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 149 0.0028
1 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 57 0.0024
2 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 40 0.0021
3 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 164 0.0013
4 Kinase Inhibitor [EPC] 673 0.0013
5 Aldehyde Dehydrogenase Inhibitor [EPC] 1 0.0009
6 CCR5 Co-receptor Antagonist [EPC] 2 0.0009
7 Estrogen Receptor Antagonist [EPC] 31 0.0008
8 Hedgehog Pathway Inhibitor [EPC] 7 0.0008
9 Platinum-based Drug [EPC] 158 0.0006
See all drug classes enriched for association with ACQUIRED GENE MUTATION